CHRISTOPHER FORBES Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CHRISTOPHER FORBES.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CHRISTOPHER FORBES. CHRISTOPHER FORBES is Director in Sevion Therapeutics, Inc. ($SVON).

CHRISTOPHER FORBES in Eloxx Pharmaceuticals, Inc.

Trading Symbol: ELOX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of CHRISTOPHER FORBES: Director
Holdings: 2,026,021 shares
Current Value: $465,985
Latest Transaction: Mar 14 2008
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CHRISTOPHER FORBES in Eloxx Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	1.05	16	17	2,026,021	2 M to 2 M (0.00 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.99	325	322	2,026,021	2 M to 2 M (+0.02 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.96	1,500	1,440	2,026,021	2 M to 2 M (+0.07 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.95	1,000	950	2,026,021	2 M to 2 M (+0.05 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.90	2,659	2,393	2,026,021	2 M to 2 M (+0.13 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.89	399	355	2,026,021	2 M to 2 M (+0.02 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.88	9,201	8,097	2,026,021	2 M to 2 M (+0.46 %)
Mar 14 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.88	2,800	2,464	2,010,921	2 M to 2 M (+0.14 %)
Mar 11 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.86	7,000	6,020	1,998,021	2 M to 2 M (+0.35 %)
Mar 11 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.88	7,900	6,952	1,998,021	2 M to 2 M (+0.40 %)
Mar 12 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.84	100	84	2,008,121	2 M to 2 M (0.00 %)
Mar 12 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.88	10,000	8,800	2,008,121	2 M to 2 M (+0.50 %)
Mar 11 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.84	550	462	1,983,121	2 M to 2 M (+0.03 %)
Mar 07 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.86	9,800	8,428	1,982,571	2 M to 2 M (+0.50 %)
Mar 07 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.85	10,000	8,500	1,982,571	2 M to 2 M (+0.51 %)
Mar 06 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.81	500	405	1,962,771	2 M to 2 M (+0.03 %)
Mar 06 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.84	11,900	9,996	1,962,771	2 M to 2 M (+0.61 %)
Mar 03 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.79	900	711	1,950,371	1.9 M to 2 M (+0.05 %)
Feb 29 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.78	100	78	1,949,471	1.9 M to 1.9 M (+0.01 %)
Feb 27 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.78	5,000	3,900	1,949,371	1.9 M to 1.9 M (+0.26 %)
Feb 27 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.77	200	154	1,949,371	1.9 M to 1.9 M (+0.01 %)
Feb 27 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.75	9,000	6,750	1,949,371	1.9 M to 1.9 M (+0.46 %)
Feb 27 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.74	1,000	740	1,949,371	1.9 M to 1.9 M (+0.05 %)
Feb 26 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.80	100	80	1,934,171	1.9 M to 1.9 M (+0.01 %)
Feb 26 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.79	2,100	1,659	1,934,171	1.9 M to 1.9 M (+0.11 %)
Feb 26 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.78	2,800	2,184	1,934,171	1.9 M to 1.9 M (+0.14 %)
Feb 26 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.76	5,000	3,800	1,934,171	1.9 M to 1.9 M (+0.26 %)
Feb 25 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.79	17,000	13,430	1,924,171	1.9 M to 1.9 M (+0.89 %)
Feb 25 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.78	5,900	4,602	1,924,171	1.9 M to 1.9 M (+0.31 %)
Feb 25 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.77	400	308	1,924,171	1.9 M to 1.9 M (+0.02 %)
Feb 22 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.80	20,000	16,000	1,900,871	1.9 M to 1.9 M (+1.06 %)
Feb 22 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.75	18,300	13,725	1,900,871	1.9 M to 1.9 M (+0.97 %)
Feb 20 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.75	6,450	4,838	1,862,571	1.9 M to 1.9 M (+0.35 %)
Feb 20 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.70	8,550	5,985	1,862,571	1.9 M to 1.9 M (+0.46 %)
Dec 13 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.94	146,000	136,598	1,782,571	1.6 M to 1.8 M (+8.92 %)
Dec 17 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	1.09	50,000	54,500	250,000
Dec 17 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.91	15,000	13,601	1,847,571	1.8 M to 1.8 M (+0.82 %)
Dec 13 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.95	50,000	47,500	1,832,571	1.8 M to 1.8 M (+2.80 %)
Dec 12 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.78	50,000	38,870	1,636,571	1.6 M to 1.6 M (+3.15 %)
Dec 11 2007	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.54	54,000	28,928	1,586,571	1.5 M to 1.6 M (+3.52 %)
Dec 18 2006	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	1.08	30,000	32,400	200,000
Oct 13 2006	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	1.18	441,501	520,971	635,430
Oct 13 2006	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Grant	A	1.07	883,002	944,812	1,532,571	649.6 K to 1.5 M (+135.94 %)
Mar 20 2006	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	1.50	40,000	60,000	649,569	609.6 K to 649.6 K (+6.56 %)
Dec 16 2005	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	1.40	30,000	42,000	363,929
Dec 20 2004	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	3.45	20,000	69,000	333,929

Page: 1